Brain Tumors: Diagnostic Approach and Management

Diagnostic Approach

MRI is the preferred initial imaging study for suspected brain tumors, as it can identify multiple lesions when a prior CT identifies only a single tumor 1
Gadolinium-enhanced MRI is specifically recommended as the gold standard for brain tumor diagnosis due to its superior sensitivity 2
The National Comprehensive Cancer Network recommends MRI as the gold standard for diagnosing brain tumors, not CT scan, due to its high resolution and sensitivity in identifying brain metastases, particularly when multiple lesions are present 1

Brain tumor symptoms are primarily determined by tumor location rather than size, as specific neurological deficits correspond to the affected brain regions 4

Corticosteroids, particularly dexamethasone, are a cornerstone in managing brain tumors to control perilesional vasogenic edema, according to the National Comprehensive Cancer Network 1, 5
The European Federation of Neurological Sciences recommends starting dosages of dexamethasone between 4-8 mg/day for managing brain tumor-related edema, although this is based on a summary from Praxis Medical Insights, the National Comprehensive Cancer Network also recommends corticosteroids for this purpose 1, 5
Ideally, steroid dose should be tapered as quickly as the clinical situation allows because of toxicity associated with long-term (>3 weeks) use, as recommended by the National Comprehensive Cancer Network 1

Indications for surgery include: diagnostic uncertainty, symptoms refractory to steroids, bulky metastases (>3-4 cm), and solitary brain metastases, according to Neuro-Oncology 5
Postoperative MRI should be performed within 24-72 hours after surgery to document the extent of disease after surgical intervention, as recommended by the National Comprehensive Cancer Network 4

Radiation therapy options include standard fractionated external-beam RT, stereotactic radiosurgery, and whole-brain RT, according to the National Comprehensive Cancer Network 4
Whole-brain RT and stereotactic radiosurgery are used primarily for brain metastases, while standard fractionated RT is more common for primary brain tumors, as recommended by the National Comprehensive Cancer Network 4

The natural history of untreated cerebral metastases is poor, with median survival reported as less than 2 months, although this is based on a summary from Praxis Medical Insights, the National Comprehensive Cancer Network also discusses prognosis 4
There is no evidence that prognosis differs significantly between males and females with brain tumors, according to the National Comprehensive Cancer Network and Neuro-Oncology 2, 4

Prophylactic anticonvulsants are not recommended for patients with no history of seizures, according to the American Academy of Neurology and the National Comprehensive Cancer Network 1
For patients with incidentally discovered brain metastasis without significant mass effect or edema, withholding steroids and antiepilepsy medication may be appropriate, as recommended by the National Comprehensive Cancer Network 1
The exact determination of tumor number on MRI is important as it guides treatment decisions - single metastasis occurs in approximately 25-33% of patients, according to the National Comprehensive Cancer Network 1